Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global PARP Inhibitors for Breast Cancer Market Size Growth Rate by Type (2014-2025) 1.4.2 Olaparib 1.4.3 Talazoparib 1.5 Market by Application 1.5.1 Global PARP Inhibitors for Breast Cancer Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Drug Center 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 PARP Inhibitors for Breast Cancer Market Size 2.2 PARP Inhibitors for Breast Cancer Growth Trends by Regions 2.2.1 PARP Inhibitors for Breast Cancer Market Size by Regions (2014-2025) 2.2.2 PARP Inhibitors for Breast Cancer Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 PARP Inhibitors for Breast Cancer Market Size by by Players 3.1.1 Global PARP Inhibitors for Breast Cancer Revenue by by Players (2014-2019) 3.1.2 Global PARP Inhibitors for Breast Cancer Revenue Market Share by by Players (2014-2019) 3.1.3 Global PARP Inhibitors for Breast Cancer Market Concentration Ratio (CR5 and HHI) 3.2 PARP Inhibitors for Breast Cancer Key Players Head office and Area Served 3.3 Key Players PARP Inhibitors for Breast Cancer Product/Solution/Service 3.4 Date of Enter into PARP Inhibitors for Breast Cancer Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) 4.2 Global PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) 5 United States 5.1 United States PARP Inhibitors for Breast Cancer Market Size (2014-2019) 5.2 PARP Inhibitors for Breast Cancer Key Players in United States 5.3 United States PARP Inhibitors for Breast Cancer Market Size by Type 5.4 United States PARP Inhibitors for Breast Cancer Market Size by Application 6 Europe 6.1 Europe PARP Inhibitors for Breast Cancer Market Size (2014-2019) 6.2 PARP Inhibitors for Breast Cancer Key Players in Europe 6.3 Europe PARP Inhibitors for Breast Cancer Market Size by Type 6.4 Europe PARP Inhibitors for Breast Cancer Market Size by Application 7 China 7.1 China PARP Inhibitors for Breast Cancer Market Size (2014-2019) 7.2 PARP Inhibitors for Breast Cancer Key Players in China 7.3 China PARP Inhibitors for Breast Cancer Market Size by Type 7.4 China PARP Inhibitors for Breast Cancer Market Size by Application 8 Japan 8.1 Japan PARP Inhibitors for Breast Cancer Market Size (2014-2019) 8.2 PARP Inhibitors for Breast Cancer Key Players in Japan 8.3 Japan PARP Inhibitors for Breast Cancer Market Size by Type 8.4 Japan PARP Inhibitors for Breast Cancer Market Size by Application 9 Southeast Asia 9.1 Southeast Asia PARP Inhibitors for Breast Cancer Market Size (2014-2019) 9.2 PARP Inhibitors for Breast Cancer Key Players in Southeast Asia 9.3 Southeast Asia PARP Inhibitors for Breast Cancer Market Size by Type 9.4 Southeast Asia PARP Inhibitors for Breast Cancer Market Size by Application 10 India 10.1 India PARP Inhibitors for Breast Cancer Market Size (2014-2019) 10.2 PARP Inhibitors for Breast Cancer Key Players in India 10.3 India PARP Inhibitors for Breast Cancer Market Size by Type 10.4 India PARP Inhibitors for Breast Cancer Market Size by Application 11 Central & South America 11.1 Central & South America PARP Inhibitors for Breast Cancer Market Size (2014-2019) 11.2 PARP Inhibitors for Breast Cancer Key Players in Central & South America 11.3 Central & South America PARP Inhibitors for Breast Cancer Market Size by Type 11.4 Central & South America PARP Inhibitors for Breast Cancer Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 PARP Inhibitors for Breast Cancer Introduction 12.1.4 AstraZeneca Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019) 12.1.5 AstraZeneca Recent Development 12.2 Everest Pharmaceuticals 12.2.1 Everest Pharmaceuticals Company Details 12.2.2 Company Description and Business Overview 12.2.3 PARP Inhibitors for Breast Cancer Introduction 12.2.4 Everest Pharmaceuticals Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019) 12.2.5 Everest Pharmaceuticals Recent Development 12.3 Pfizer 12.3.1 Pfizer Company Details 12.3.2 Company Description and Business Overview 12.3.3 PARP Inhibitors for Breast Cancer Introduction 12.3.4 Pfizer Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019) 12.3.5 Pfizer Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table PARP Inhibitors for Breast Cancer Key Market Segments Table Key Players PARP Inhibitors for Breast Cancer Covered Table Global PARP Inhibitors for Breast Cancer Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global PARP Inhibitors for Breast Cancer Market Share by TypeType in 2018 & 2025 Figure Olaparib Figures Table Key Players of Olaparib Figure Talazoparib Figures Table Key Players of Talazoparib Table Global PARP Inhibitors for Breast Cancer Market Size Growth by Application 2019-2025 (Million US$) Figure Global PARP Inhibitors for Breast Cancer Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinic Case Studies Figure Drug Center Case Studies Figure Other Case Studies Figure PARP Inhibitors for Breast Cancer Report Years Considered Table Global PARP Inhibitors for Breast Cancer Market Size 2014-2025 (Million US$) Figure Global PARP Inhibitors for Breast Cancer Market Size and Growth Rate 2014-2025 (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Size by Regions 2019-2025 (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Size by Regions 2019-2025 (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Share by Regions 2014-2019 Figure Global PARP Inhibitors for Breast Cancer Market Share by Regions 2014-2019 Figure Global PARP Inhibitors for Breast Cancer Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global PARP Inhibitors for Breast Cancer Revenue by by Players (2014-2019) (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Share by by Players (2014-2019) Figure Global PARP Inhibitors for Breast Cancer Market Share by by Players in 2018 Table Global PARP Inhibitors for Breast Cancer by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players PARP Inhibitors for Breast Cancer Product/Solution/Service Table Date of Enter into PARP Inhibitors for Breast Cancer Market Table Mergers & Acquisitions, Expansion Plans Table Global PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Size Share by Type (2014-2019) Figure Global PARP Inhibitors for Breast Cancer Market Size Market Share by Type (2014-2019) Table Global PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Global PARP Inhibitors for Breast Cancer Market Size Share by Application (2014-2019) Figure Global PARP Inhibitors for Breast Cancer Market Size Market Share by Application (2014-2019) Figure Global PARP Inhibitors for Breast Cancer Revenue Market Share by Application in 2018 Figure United States PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table United States Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table United States Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table United States PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table United States PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table United States PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table United States PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure Europe PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table Europe Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table Europe Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table Europe PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Europe PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table Europe PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Europe PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure China PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table China Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table China Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table China PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table China PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table China PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table China PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure Japan PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table Japan Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table Japan Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table Japan PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Japan PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table Japan PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Japan PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure Southeast Asia PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table Southeast Asia PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Southeast Asia PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table Southeast Asia PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Southeast Asia PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure India PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table India Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table India Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table India PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table India PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table India PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table India PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Figure Central & South America PARP Inhibitors for Breast Cancer Market Size 2014-2019 (Million US$) Table Central & South America Key Players PARP Inhibitors for Breast Cancer Revenue (2018-2019) (Million US$) Table Central & South America Key Players PARP Inhibitors for Breast Cancer Market Share (2018-2019) Table Central & South America PARP Inhibitors for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Central & South America PARP Inhibitors for Breast Cancer Market Share by Type (2014-2019) Table Central & South America PARP Inhibitors for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Central & South America PARP Inhibitors for Breast Cancer Market Share by Application (2014-2019) Table AstraZeneca Company Details Table AstraZeneca Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019) (Million US$) Figure AstraZeneca Revenue Growth Rate in PARP Inhibitors for Breast Cancer Business (2014-2019) Table AstraZeneca Recent Development Table Everest Pharmaceuticals Company Details Table Everest Pharmaceuticals Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019)(Million US$) Figure Everest Pharmaceuticals Revenue Growth Rate in PARP Inhibitors for Breast Cancer Business (2014-2019) Table Everest Pharmaceuticals Recent Development Table Pfizer Company Details Table Pfizer Revenue in PARP Inhibitors for Breast Cancer Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in PARP Inhibitors for Breast Cancer Business (2014-2019) Table Pfizer Recent Development Table Global PARP Inhibitors for Breast Cancer Market Size by Regions (Million US$) 2019-2025 Figure Global PARP Inhibitors for Breast Cancer Market Size Share by Regions (2019-2025) Figure Global PARP Inhibitors for Breast Cancer Market Size Share by Regions in 2025 Figure United States PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Europe PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure China PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Japan PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure India PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Central & South America PARP Inhibitors for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Table Global PARP Inhibitors for Breast Cancer Market Size by Product (2019-2025) (Million US$) Figure Global PARP Inhibitors for Breast Cancer Market Size by Product (2019-2025) Figure Global PARP Inhibitors for Breast Cancer Market Size by Product in 2025 Table Global PARP Inhibitors for Breast Cancer Market Size by Application (2019-2025) (Million US$) Figure Global PARP Inhibitors for Breast Cancer Market Size by Application (2019-2025) Figure Global PARP Inhibitors for Breast Cancer Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Everest Pharmaceuticals Pfizer